School of Public Health and Management, Guangxi University of Chinese Medicine, Nanning 530022, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Feb 15;24(2):204-209. doi: 10.7499/j.issn.1008-8830.2110041.
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by progressive muscular weakness and atrophy. SMA, as an inherited disease, is the leading cause of death in infants and young children. Rapid progress has been made in the research field of SMA in recent years, and some related treatment drugs have been successfully approved for marketing. This article reviews the recent research advances in the treatment of SMA.
脊髓性肌萎缩症（SMA）是一种常染色体隐性神经肌肉疾病，其特征是进行性肌肉无力和萎缩。SMA 作为一种遗传病，是婴儿和幼儿死亡的主要原因。近年来，SMA 研究领域取得了快速进展，一些相关的治疗药物已成功获准上市。本文综述了 SMA 治疗的最新研究进展。
